about
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarkerDiagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral DataMicroheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.Anticancer Activity of Pterostilbene in Human Ovarian Cancer Cell LinesDetection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkersClinical proteomics: translating benchside promise into bedside reality.Cancer diagnosis using proteomic patterns.Promising directions for the diagnosis and management of gynecological cancers.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancerCorrelation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer.Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods.
P2860
Q24648238-AFB640B6-5DA6-4D00-A8CC-0BC7821B5F54Q24798791-F0022BB9-AF17-48AC-B9BB-D5507118128DQ24811949-BEF6BF2D-E7EF-45A0-A39F-1BF4164E5A25Q31005059-F2B275F4-1B64-49A6-8697-986B2D0CEA1BQ31154011-30DDEE07-612B-4023-9917-750AF547E0A0Q33222839-2A77E4DF-90F2-4615-9CCD-83C4B48D9DE0Q33583799-A66E8159-84B8-465C-A2E9-394A11625390Q33642806-EEEC26D3-E9ED-4485-AA11-F1D7F25727EAQ33888129-684843C5-7DD2-4BA6-AFD1-946DF728CBC6Q33890172-5AA3AF83-1B88-4DB1-925A-0A36DE39DF3DQ34412873-D3F3ABE4-01AA-4B7A-B406-AF1925F6185DQ34810370-3872D23C-561E-4D0E-8BAF-9A2E53661537Q35183635-F319B469-5CB4-4022-B9FE-8758B407A8FCQ35648859-A811CAA6-FB9B-4E99-9DD5-35A7E684681CQ36582422-E45FB71D-D235-4AC2-8083-7AB9DB20157AQ36713610-4F1A097E-E100-4713-98A8-C81BDFB0B54BQ37376643-747A8283-FFA4-4276-AE11-2261E1871E93Q44219922-FAF9A70D-F8A0-44A4-972F-2A0220BD225FQ50939160-0DDC3B79-CE4C-4F6B-945D-7BD91DF824A3
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recent developments in ovarian cancer screening.
@ast
Recent developments in ovarian cancer screening.
@en
type
label
Recent developments in ovarian cancer screening.
@ast
Recent developments in ovarian cancer screening.
@en
prefLabel
Recent developments in ovarian cancer screening.
@ast
Recent developments in ovarian cancer screening.
@en
P1476
Recent developments in ovarian cancer screening.
@en
P2093
P356
10.1097/00001703-200002000-00007
P577
2000-02-01T00:00:00Z